the remarkable success of this formulation has occurred primarily because it provides extremely low doses of both hormonal constituents yet still gives most users a very acceptable bleeding pattern : the incidence of breakthrough bleeding is about 6 % and of amenorrhea , less than 3 % .
C0019080
bleeding
C0025874
breakthrough bleeding